V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270018183 | 270009491 | 1.57 | 99.4 | Palliative (P) | 2017-04-10 | 2017-05-04 | CHLVPP | N | N | 270016074 | CHLVPP |
| 270018184 | 270009500 | null | null | Curative (C) | 2017-04-13 | 2017-09-19 | DHAP | 02 | N | 270016124 | DHAP |
| 270018185 | 270009503 | 1.73 | 84.1 | Not known (9) | 2017-05-16 | 2017-06-05 | Fluorouricil + Folonic Acid (MdG) | N | N | 270016133 | FLUOROURACIL |
| 270018186 | 270009507 | 1.8 | 59.2 | Palliative (P) | 2013-11-24 | 2013-11-24 | Capecitabine (14 day) + Irinotecan | N | N | 270016150 | CAPECITABINE + IRINOTECAN |
| 270018187 | 270018404 | 1.77 | 61.3 | Palliative (P) | 2016-01-29 | 2016-01-30 | CHLVPP | 02 | N | 270016155 | CHLVPP |
| 270018188 | 270009512 | 1.61 | 73 | Neo-adjuvant (N) | 2016-08-31 | 2016-09-07 | CAPECITABINE + IRINOTECAN | 2 | null | 270016186 | CAPECITABINE + IRINOTECAN |
| 270018190 | 270009518 | null | 96.8 | null | 2015-01-12 | 2015-01-19 | CAPECITABINE + IRINOTECAN | N | null | 270016209 | CAPECITABINE + IRINOTECAN |
| 270018191 | 270009523 | 1.73 | 68 | Palliative (P) | 2015-11-12 | 2016-08-13 | CHLVPP | N | N | 270016222 | CHLVPP |
| 270018192 | 270009529 | 1.63 | 62 | Neo-adjuvant (N) | 2018-04-27 | 2018-05-27 | CISPLATIN + FLUOROURACIL | N | N | 270016230 | CISPLATIN + FLUOROURACIL |
| 270018193 | 270014458 | 1.68 | null | Palliative (P) | 2018-11-11 | 2018-11-11 | CHLVPP | N | N | 270016243 | CHLVPP |
| 270018194 | 270009537 | 1.79 | 96 | Palliative (P) | 2018-12-12 | 2019-01-01 | CHLVPP | N | N | 270016250 | CHLVPP |
| 270018195 | 270009542 | 1.66 | 70.1 | Palliative (P) | 2018-10-15 | 2018-10-22 | CISPLATIN + FLUOROURACIL | 02 | N | 270016266 | CISPLATIN + FLUOROURACIL |
| 270018196 | 270009546 | 1.58 | null | null | 2013-11-22 | 2013-11-23 | DHAP | null | null | 270016270 | DHAP |
| 270018197 | 270009549 | 1.85 | 69 | Adjuvant (A) | 2017-04-12 | 2017-04-12 | Capecitabine 35days + RT | N | null | 270016272 | CAPECITABINE + RT |
| 270018199 | 270009553 | null | null | Palliative (P) | 2013-09-09 | 2014-07-24 | Fluorouracil + Folinic Acid Weekly | 02 | N | 270016291 | FLUOROURACIL |
| 270018200 | 270014469 | 1.54 | 85.4 | Palliative (P) | 2015-04-19 | 2015-04-19 | Capecitabine (21 day) + Irinotecan | 02 | N | 270016297 | CAPECITABINE + IRINOTECAN |
| 270018201 | 270009564 | null | null | Palliative (P) | 2019-03-28 | 2019-04-10 | Escalated BEACOP Dac | N | N | 270016323 | NOT MATCHED |
| 270018202 | 270016972 | null | 95.4 | Curative (C) | 2017-12-17 | 2018-06-21 | DHAP | N | N | 270016329 | DHAP |
| 270018203 | 270009566 | 1.69 | 71.2 | Adjuvant (A) | 2018-11-11 | 2018-11-11 | Capecitabine 35days + RT | 02 | N | 270016336 | CAPECITABINE + RT |
| 270018204 | 270009568 | 1.69 | 69 | Palliative (P) | 2015-02-12 | 2015-02-19 | CHLVPP | N | N | 270016339 | CHLVPP |
| 270018205 | 270009574 | 1.75 | 53 | Neo-adjuvant (N) | 2014-11-04 | 2015-02-05 | CISPLATIN + FLUOROURACIL | N | N | 270016358 | CISPLATIN + FLUOROURACIL |
| 270018206 | 270009579 | 1.7 | 69 | Curative (C) | 2018-05-18 | 2018-05-25 | DHAP | 2 | null | 270016371 | DHAP |
| 270018207 | 270009585 | 1.76 | 78.2 | Adjuvant (A) | 2015-01-05 | 2015-01-21 | Capecitabine (14 day) + Irinotecan | N | N | 270016378 | CAPECITABINE + IRINOTECAN |
| 270018208 | 270009588 | 1.9 | 45.8 | Palliative (P) | 2013-07-26 | 2013-07-28 | Cisplatin +Fluorouracil (3 wk) | N | N | 270016384 | CISPLATIN + FLUOROURACIL |
| 270018209 | 270009591 | 1.7 | 72.1 | Curative (C) | 2019-03-30 | 2019-07-17 | DHAP | N | N | 270016396 | DHAP |
| 270018210 | 270018415 | null | 81.7 | Curative (C) | 2014-06-05 | 2014-11-08 | DHAP | 2 | null | 270016405 | DHAP |
| 270018211 | 270009598 | 1.61 | 90.2 | null | 2014-10-24 | 2015-03-13 | CHLVPP | 02 | null | 270016406 | CHLVPP |
| 270018212 | 270009602 | 0 | null | Palliative (P) | null | 2017-11-19 | Trifluridine + Tipiracil | null | null | 270016414 | TRIFLURIDINE + TIPIRACIL |
| 270018213 | 270014492 | 1.63 | 70.75 | null | 2019-02-05 | 2019-02-12 | CAPECITABINE + IRINOTECAN | 02 | Y | 270016418 | CAPECITABINE + IRINOTECAN |
| 270018214 | 270014493 | null | 52.5 | Palliative (P) | 2018-02-18 | 2018-02-25 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016421 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270018215 | 270009607 | null | null | Neo-adjuvant (N) | null | 2016-02-14 | Bevacizumab + Oxaliplatin +MdG | null | null | 270016426 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270018216 | 270009610 | 1.56 | 57.4 | Palliative (P) | 2018-03-09 | 2018-03-13 | DHAP | 02 | N | 270016434 | DHAP |
| 270018217 | 270014498 | null | 97 | Neo-adjuvant (N) | 2016-02-29 | 2016-03-29 | CISPLATIN + FLUOROURACIL | null | null | 270016438 | CISPLATIN + FLUOROURACIL |
| 270018218 | 270009613 | 1.64 | 57.8 | Palliative (P) | 2018-04-25 | 2018-04-25 | Capecitabine (21 day) + Irinotecan | N | Y | 270016441 | CAPECITABINE + IRINOTECAN |
| 270018219 | 270009617 | 1.8 | null | Adjuvant (A) | 2016-02-20 | 2016-02-26 | null | 02 | 2 | 270016443 | NOT MATCHED |
| 270018220 | 270009622 | 1.73 | 71.7 | Palliative (P) | 2017-08-19 | 2017-09-15 | CHLVPP | 02 | N | 270016459 | CHLVPP |
| 270018221 | 270019234 | 1.58 | 142 | Curative (C) | 2015-04-01 | 2015-04-13 | CHOP R - 21 days | N | N | 270016464 | CHOP R |
| 270018222 | 270014504 | 1.68 | 88.1 | Curative (C) | 2013-12-06 | 2013-12-06 | CAPECITABINE + RT | N | N | 270016482 | CAPECITABINE + RT |
| 270018223 | 270016994 | 1.79 | 101.7 | Curative (C) | 2015-06-02 | 2015-06-03 | DHAP | N | N | 270016490 | DHAP |
| 270018224 | 270014508 | null | null | Palliative (P) | 2019-02-07 | 2019-02-20 | DHAP | N | N | 270016502 | DHAP |
| 270018225 | 270009638 | 1.73 | 66.7 | Adjuvant (A) | 2016-11-30 | 2016-12-13 | Capecitabine (21 day) + Irinotecan | 02 | N | 270016525 | CAPECITABINE + IRINOTECAN |
| 270018226 | 270009641 | 1.63 | null | Curative (C) | 2017-12-16 | 2018-04-09 | Capecitabine 42days + RT | N | N | 270016528 | CAPECITABINE + RT |
| 270018227 | 270018426 | 1.84 | 89 | Curative (C) | 2016-03-06 | 2016-03-31 | CHOP R - 21 days | 02 | N | 270016542 | CHOP R |
| 270018228 | 270014514 | null | 86.4 | Not known (9) | 2017-05-04 | 2017-05-11 | FLUOROURACIL | 2 | N | 270016559 | FLUOROURACIL |
| 270018229 | 270019237 | 1.72 | 84.5 | Palliative (P) | 2013-10-02 | 2014-02-19 | Capecitabine (21 day) + Irinotecan | N | null | 270016570 | CAPECITABINE + IRINOTECAN |
| 270018230 | 270017003 | 1.6 | 63.2 | Curative (C) | null | 2019-03-19 | Capecitabine (14 day) + Irinotecan | N | N | 270016578 | CAPECITABINE + IRINOTECAN |
| 270018231 | 270009656 | 1.96 | 87 | Neo-adjuvant (N) | 2015-08-23 | 2017-12-02 | CISPLATIN + FLUOROURACIL | N | N | 270016596 | CISPLATIN + FLUOROURACIL |
| 270018232 | 270009659 | 1.78 | 85.9 | Palliative (P) | null | 2015-04-16 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016605 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270018233 | 270019239 | 1.9 | 59 | Palliative (P) | 2017-11-19 | 2017-12-12 | CHOP R - 21 days | N | N | 270016607 | CHOP R |
| 270018234 | 270009665 | 1.65 | 104 | null | 2018-07-10 | 2018-10-08 | CHOP R - 21 days | N | N | 270016614 | CHOP R |